Medication info
Pactamin D3 Tablet 25000 IU (Cholecalciferol Concentrated Powder)

Pactamin D3 Tablet 25000 IU (Cholecalciferol Concentrated Powder)

Prescription medicationTabletOral
Ingredient · strength
Cholecalciferol Concentrate Powder›250mg
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
4 tablets/Pitipi
Approval status
Active

MFDS item code 201904637 · Notified 2019.07.09

Summary

Main use
Prevention and treatment of vitamin D deficiency; adjunctive treatment of osteoporosis in patients with vitamin D deficiency or at risk of vitamin D deficiency
Who takes it
Adults · Children
Adult dose
This medicine may be swallowed whole or crushed. This medicine may be taken with food. Treatment of vitamin D deficiency: Adults: Take 2 tablets (equivalent to 50,000IU of cholecalciferol) once weekly for 6 weeks. Maintenance therapy after treatment of vitamin D deficiency: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly. For patients at high risk of vitamin D deficiency, up to 2 tablets (equivalent to 50,000IU of cholecalciferol) may be taken once monthly as prescribed by a physician. Approximately 3-4 months after starting maintenance therapy, the blood 25-hydroxyvitamin D level should be checked to confirm that the target vitamin D level has been reached Prevention of vitamin D deficiency: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly. For patients at high risk of vitamin D deficiency, up to 2 tablets (equivalent to 50,000IU of cholecalciferol) may be taken once monthly as prescribed by a physician. Adjunctive treatment of osteoporosis: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly.
Child dose
Treatment of vitamin D deficiency: Adolescents aged 12 years and older: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once every 2 weeks for 6 weeks. Prevention of vitamin D deficiency: Adolescents aged 12 years and older: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once every 6 weeks.

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency; adjunctive treatment of osteoporosis in patients with vitamin D deficiency or at risk of vitamin D deficiency

  • Vitamin D deficiency
View approved original text

This medication is used to prevent and treat vitamin D deficiency. Additionally, it helps in the treatment of osteoporosis in patients with or at risk of vitamin D deficiency. Therefore, it aids in maintaining skeletal health and improving bone-related diseases.

How to take

Adult dose

This medicine may be swallowed whole or crushed. This medicine may be taken with food. Treatment of vitamin D deficiency: Adults: Take 2 tablets (equivalent to 50,000IU of cholecalciferol) once weekly for 6 weeks. Maintenance therapy after treatment of vitamin D deficiency: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly. For patients at high risk of vitamin D deficiency, up to 2 tablets (equivalent to 50,000IU of cholecalciferol) may be taken once monthly as prescribed by a physician. Approximately 3-4 months after starting maintenance therapy, the blood 25-hydroxyvitamin D level should be checked to confirm that the target vitamin D level has been reached Prevention of vitamin D deficiency: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly. For patients at high risk of vitamin D deficiency, up to 2 tablets (equivalent to 50,000IU of cholecalciferol) may be taken once monthly as prescribed by a physician. Adjunctive treatment of osteoporosis: Adults: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once monthly.

Child dose

Treatment of vitamin D deficiency: Adolescents aged 12 years and older: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once every 2 weeks for 6 weeks. Prevention of vitamin D deficiency: Adolescents aged 12 years and older: Take 1 tablet (equivalent to 25,000IU of cholecalciferol) once every 6 weeks.

Precautions

This medication should not be used in certain patients. First, patients with allergic reactions to the ingredients of this medication should not be administered. Moreover, patients who are in a state of vitamin D excess, or those with kidney stones or nephrocalcinosis should not take this medication. Patients with hypercalcemia or hypercalciuria, and those with diseases that can lead to such conditions should also avoid this medication. It should not be administered to patients with severe renal impairment. This medication should be used cautiously in patients with weakened kidney function or granulomatous diseases such as sarcoidosis. In such cases, blood and urine calcium levels should be periodically checked to monitor for abnormalities. Side effects may occur when taking this medication. Rarely, symptoms such as skin itching, rash, and hives may appear, and nausea or vomiting may be experienced. Additionally, there is a rare possibility that blood calcium levels may increase, thus caution is necessary. This medication must be used particularly carefully in patients with decreased kidney function, and calcium and phosphate levels should be regularly checked. It is essential to consistently monitor blood calcium concentrations and kidney function during long-term use. Elderly patients or those prone to stone formation who are taking heart disease medications or diuretics require even more careful management. When using this medication with other vitamin D-containing drugs, the total vitamin D dosage should be adjusted accordingly. When starting vitamin D supplementation, individual calcium status and dietary habits should also be taken into consideration. This medication can interact with certain drugs. For example, phenytoin or barbiturates may reduce the effectiveness of this medication. Additionally, cholestyramine or laxatives may hinder the absorption of this medication. Glucocorticoids may also reduce its effectiveness, so caution is required. An increase in vitamin D concentration can raise blood calcium levels, affecting the heart. This may increase the risk of cardiac arrhythmia; therefore, regular ECG tests and blood tests should be conducted. Taking this medication alongside thiazide diuretics can decrease calcium excretion and heighten the risk of hypercalcemia; hence blood tests are necessary. Pregnant women should consult a physician regarding the use of this medication, and dosage adjustments may be necessary if needed. Nursing mothers should also consider that this medication can pass into breast milk and its effects on newborns. This medication is not recommended for children under 12 years of age. In case of overdose, blood calcium levels may rise dangerously high, and symptoms such as nausea, vomiting, thirst, drowsiness, and dizziness may occur. In this case, discontinue the medication immediately and ensure adequate hydration. When storing this medication, it should be kept in its original packaging away from light and moisture at temperatures below 25 degrees Celsius.

Side effects

  • Hypersensitivity
  • nausea
  • vomiting
  • hypercalcemia
  • hypercalciuria
  • pruritus
  • rash
  • urticaria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that prevents light exposure. Additionally, it is important to store it at a cool temperature below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

4 tablets/Pitipi

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.